Post a Free Blog

Submit A Press Release

Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Filter by Categories
Action
Animation
ATP Tour (ATP)
Auto Racing
Baseball
Basketball
Boxing
Breaking News
Business
Business
Business Newsletter
Call of Duty (CALLOFDUTY)
Canadian Football League (CFL)
Car
Celebrity
Champions Tour (CHAMP)
Comedy
CONCACAF
Counter Strike Global Offensive (CSGO)
Crime
Dark Comedy
Defense of the Ancients (DOTA)
Documentary and Foreign
Drama
eSports
European Tour (EPGA)
Fashion
FIFA
FIFA Women’s World Cup (WWC)
FIFA World Cup (FIFA)
Fighting
Football
Formula 1 (F1)
Fortnite
Golf
Health
Hockey
Horror
IndyCar Series (INDY)
International Friendly (FRIENDLY)
Kids & Family
League of Legends (LOL)
LPGA
Madden
Major League Baseball (MLB)
Mixed Martial Arts (MMA)
MLS
Movie and Music
Movie Trailers
Music
Mystery
NASCAR Cup Series (NAS)
National Basketball Association (NBA)
National Football League (NFL)
National Hockey League (NHL)
National Women's Soccer (NWSL)
NBA Development League (NBAGL)
NBA2K
NCAA Baseball (NCAABBL)
NCAA Basketball (NCAAB)
NCAA Football (NCAAF)
NCAA Hockey (NCAAH)
Olympic Mens (OLYHKYM)
Other
Other Sports
Overwatch
PGA
Politics
Premier League (PREM)
Romance
Sci-Fi
Science
Soccer
Sports
Sports
Technology
Tennis
Thriller
Truck Series (TRUCK)
True Crime
Ultimate Fighting Championship (UFC)
US
Valorant
Western
Women’s National Basketball Association (WNBA)
Women’s NCAA Basketball (WNCAAB)
World
World Cup Qualifier (WORLDCUP)
WTA Tour (WTA)
Xfinity (XFT)
XFL
0
-- Advertisement --spot_img
HomeBusinessUnited Parks Q1 Misses Estimates as Attendance Slips, But Optimism Remains for...

United Parks Q1 Misses Estimates as Attendance Slips, But Optimism Remains for 2025

Add to Favorite
Added to Favorite


United Parks & Resorts Inc. (NYSE:PRKS) reported a disappointing Q1 2025, missing both top- and bottom-line estimates and weighing on its premarket performance.

Q1 2025 Financial Highlights

Net Loss: $16.1 million (–$0.29/share) vs. –$11.2 million (–$0.17/share) LY; consensus expected –$0.21/share.

Revenue: $286.9 million, down 3.5% YoY vs. $295.8 million expected.

Attendance: 3.39 million guests, –1.7% YoY, hurt by Easter and Spring Break shifting into Q2.

Per Capita Spend: +1.1%, a record high and the 19th increase in 20 quarters.

Despite the calendar headwind, CEO Marc Swanson highlighted “strong bookings trends” and new attractions poised to drive full-year growth.

Why the Shortfall?

Holiday Timing Shift: Easter and Spring Break moved largely into April, pulling a material chunk of attendance (and admission revenue) into Q2.

Lower Admission Yield: Core ticket revenue dipped, only partially offset by higher ancillary spending (F&B, merchandise, etc.).

Fixed Cost Leverage: Theme parks’ high operating leverage magnifies revenue misses into deeper losses.

Keeping Track of Filings & Guidance
Stakeholders should review United Parks’ detailed Q1 results and management commentary in its 10-Q filing. You can access the official report and future updates via the SEC Filings API, which provides immediate access to all of PRKS’s regulatory disclosures:View United Parks’ latest SEC filings

What’s Next

Q2 Performance: Spring Break and Easter revenue now front-loaded into Q2—expect stronger sequential growth.

New Attractions: Monitor early attendance and spend uplift from park additions later this year.

Full-Year Outlook: Management still projects record revenue and adjusted EBITDA for 2025; validate these targets against upcoming quarterly earnings calls.

By pairing the SEC Filings API’s real-time access with quarterly earnings commentary, investors can stay aligned with United Parks’ recovery trajectory and management’s evolving guidance.

Subscribe to get Latest News Updates

Latest News

You may like more
more

U.S. and China Agree 90-Day Tariff Pause, Temporarily Capping Levies at 10 percent

After intense weekend negotiations, the United States and China...

Magnificent Seven Surge as U.S.–China Tariffs Come Down

Premarket trading on Monday saw the Magnificent Seven—Tesla, Amazon,...

Lilly’s Zepbound Outshines Wegovy in First Head-to-Head Trial

Eli Lilly announced that its obesity therapy Zepbound delivered...